Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO1999041267) 2-(PURIN-9-YL) -TETRAHYDROFURAN-3, 4-DIOL DERIVATIVES
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1999/041267 International Application No.: PCT/EP1999/000915
Publication Date: 19.08.1999 International Filing Date: 12.02.1999
Chapter 2 Demand Filed: 26.07.1999
IPC:
C07H 19/16 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
H
SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
19
Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof
02
sharing nitrogen
04
Heterocyclic radicals containing only nitrogen as ring hetero atom
16
Purine radicals
Applicants:
GLAXO GROUP LIMITED [GB/GB]; Glaxo Wellcome House Berkeley Avenue Greenford Middlesex UB6 0NN, GB (AllExceptUS)
CHAN, Chuen [GB/GB]; GB (UsOnly)
COOK, Caroline, Mary [GB/GB]; GB (UsOnly)
COX, Brian [GB/GB]; GB (UsOnly)
COUSINS, Richard, Peter, Charles [GB/GB]; GB (UsOnly)
DYKE, Hazel, Joan [GB/GB]; GB (UsOnly)
ELLIS, Frank [GB/GB]; GB (UsOnly)
GEDEN, Joanna, Victoria [GB/GB]; GB (UsOnly)
SWANSON, Stephen [GB/GB]; GB (UsOnly)
BAYS, David [GB/GB]; GB (UsOnly)
Inventors:
CHAN, Chuen; GB
COOK, Caroline, Mary; GB
COX, Brian; GB
COUSINS, Richard, Peter, Charles; GB
DYKE, Hazel, Joan; GB
ELLIS, Frank; GB
GEDEN, Joanna, Victoria; GB
SWANSON, Stephen; GB
BAYS, David; GB
Agent:
TEUTEN, Andrew, J.; Glaxo Wellcome plc Glaxo Wellcome House Berkeley Avenue Greenford Middlesex UB6 0NN, GB
Priority Data:
9803169.314.02.1998GB
9813533.823.06.1998GB
Title (EN) 2-(PURIN-9-YL) -TETRAHYDROFURAN-3, 4-DIOL DERIVATIVES
(FR) DERIVES DE 2-(PURINE-9-YL) -TETRAHYDROFURANNE-3, 4-DIOL
Abstract:
(EN) There are provided according to the invention, novel compounds of formula (I) wherein R1, R2 and R3 are as described in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory diseases.
(FR) L'invention concerne de nouveaux composés de formule (I), dans laquelle R1, R2, et R3 sont tels que détaillés dans la description. L'invention concerne également des méthodes de préparation de ces composés, des formulations contenant ces composés, et leur utilisation en thérapie afin de traiter des maladies inflammatoires.
front page image
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, US, UZ, VN, YU, ZW
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
CZPV2000-2974HRP20000538AIS5576NO20004045SK12002000TR2000/02355
YUP-508/00MXPA/a/2000/007793APAP/P/2000/001881KR1020010082512SG74868IL137402
EP1056759US6610665JP2002503669 CN1296491CA2319009EA200000759
NZ505812AU1999026235